These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 3265243)

  • 21. [Complement-binding antibodies in women simultaneously infected with various species of Trichomonas].
    Cvetkova A; Ishev V; Andreeva N
    Wiad Parazytol; 1988; 34(2):185-90. PubMed ID: 3265240
    [No Abstract]   [Full Text] [Related]  

  • 22. Laboratory diagnosis of Trichomonas vaginalis among women attending a venereal diseases control division. First report.
    de Carli GA; Bertschinger B; Saraiva PJ; Miron CF
    Rev Latinoam Microbiol; 1987; 29(3):301-3. PubMed ID: 3326100
    [No Abstract]   [Full Text] [Related]  

  • 23. [Value of the modified Roiron medium for the simultaneous detection of urogenital tract infection by Trichomonas vaginalis and yeast-like fungi in humans].
    Małyszko E; Zajac W; Szarmach H
    Przegl Dermatol; 1976; (6 Suppl):404-10. PubMed ID: 1088589
    [No Abstract]   [Full Text] [Related]  

  • 24. Proteinases of Trichomonas vaginalis: antibody response in patients with urogenital trichomoniasis.
    Bózner P; Gombosová A; Valent M; Demes P; Alderete JF
    Parasitology; 1992 Dec; 105 ( Pt 3)():387-91. PubMed ID: 1461679
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immune response to Trichomonas vaginalis. IV. Immunochemical and immunobiological analyses of T. vaginalis antigen.
    Yano A; Yui K; Aosai F; Kojima S; Kawana T; Ovary Z
    Int Arch Allergy Appl Immunol; 1983; 72(2):150-7. PubMed ID: 6603425
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Prevalence of trichomonas vaginalis in patients with vaginal discharge in Lagos, Nigeria.
    Anorlu RI; Fagbenro Beyioku AF; Fagorala T; Abudu OO; Galadanci HS
    Niger Postgrad Med J; 2001 Dec; 8(4):183-6. PubMed ID: 11922025
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Evaluation of two serological tests for Trichomonas vaginalis infection.
    Mathews HM; Healy GR
    J Clin Microbiol; 1983 May; 17(5):840-3. PubMed ID: 6408119
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Trichomonas vaginalis, a reservoir for retention of the gonococcus. The treatment of a mixed gonorrhea-trichomonas infection].
    Ovchinnikov NM; Delektorskiĭ VV; Turanova EN; Iashkova GN
    Vestn Dermatol Venerol; 1978 Apr; (4):16-21. PubMed ID: 418592
    [No Abstract]   [Full Text] [Related]  

  • 29. Assessment of a rapid antigen detection system for Trichomonas vaginalis infection.
    Miller GA; Klausner JD; Coates TJ; Meza R; Gaydos CA; Hardick J; Leon S; Caceres CF
    Clin Diagn Lab Immunol; 2003 Nov; 10(6):1157-8. PubMed ID: 14607884
    [No Abstract]   [Full Text] [Related]  

  • 30. Suboptimal Trichomonas vaginalis Antigen Test Performance in a Low-Prevalence Sexually Transmitted Infection Community.
    Munson KL; Napierala M; Munson E
    J Clin Microbiol; 2016 Feb; 54(2):500-1. PubMed ID: 26659216
    [No Abstract]   [Full Text] [Related]  

  • 31. Detection of antitrichomonal antibodies in sera and cervical secretions in trichomoniasis.
    Romia SA; Othman TA
    J Egypt Soc Parasitol; 1991 Aug; 21(2):373-81. PubMed ID: 1875069
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A preliminary study on the relationship between Trichomonas vaginalis and cervical cancer in Egyptian women.
    Sayed el-Ahl SA; el-Wakil HS; Kamel NM; Mahmoud MS
    J Egypt Soc Parasitol; 2002 Apr; 32(1):167-78. PubMed ID: 12049252
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparative study of epitopes recognized by two monoclonal antibodies that protects mice against Trichomonas vaginalis challenge.
    Hernández H; Marcet R; Figueredo M; Garrido N; Sarracent J
    Exp Parasitol; 2008 Apr; 118(4):583-6. PubMed ID: 18031741
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Trichomonas vaginalis in Turkey--a review.
    Saygi G
    Wiad Parazytol; 2001; 47 Suppl 1():3-7. PubMed ID: 16897944
    [No Abstract]   [Full Text] [Related]  

  • 35. [Vaginal candidiasis and trichomonas. Can they be diagnosed clinically with certainty?].
    Garrocho Sandoval C; Adame Nava L; Ruiz Chávez MP; Torres Ruvalcaba AB
    Ginecol Obstet Mex; 1983 Aug; 51(316):199-203. PubMed ID: 6398785
    [No Abstract]   [Full Text] [Related]  

  • 36. Management of trichomonas vaginalis in women with suspected metronidazole hypersensitivity.
    Helms DJ; Mosure DJ; Secor WE; Workowski KA
    Am J Obstet Gynecol; 2008 Apr; 198(4):370.e1-7. PubMed ID: 18221927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic and epidemiologic significance of multinuclear and round forms of Trichomonas vaginalis].
    Szarmach H; Małyszko E; Wroński A; Niczyporuk E
    Z Hautkr; 1983 Aug; 58(16):1179-82. PubMed ID: 6605001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Trichomonas vaginalis infection activates cells through toll-like receptor 4.
    Zariffard MR; Harwani S; Novak RM; Graham PJ; Ji X; Spear GT
    Clin Immunol; 2004 Apr; 111(1):103-7. PubMed ID: 15093558
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Use of the ELISA method in the determination of antibodies to Trichomonas vaginalis].
    Gombosová A; Valent M
    Bratisl Lek Listy; 1988 Sep; 89(9):689-93. PubMed ID: 3264749
    [No Abstract]   [Full Text] [Related]  

  • 40. Antigen-specific proliferation responses of peripheral blood lymphocytes to Trichomonas vaginalis antigen in patients with Trichomonas vaginitis.
    Yano A; Aosai F; Yui K; Kojima S; Kawana T
    J Clin Microbiol; 1983 Feb; 17(2):175-80. PubMed ID: 6601112
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.